Zomedica Corp. ZOMDF
OTC PK
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 4.07% | 8.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.07% | 8.10% | |||
| Cost of Revenue | 11.06% | 4.71% | |||
| Gross Profit | 0.05% | 10.16% | |||
| SG&A Expenses | -8.71% | -1.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.99% | -0.76% | |||
| Operating Income | 16.12% | 16.67% | |||
| Income Before Tax | 15.57% | 16.82% | |||
| Income Tax Expenses | -65.38% | -33.33% | |||
| Earnings from Continuing Operations | 15.91% | 16.96% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.91% | 16.96% | |||
| EBIT | 16.12% | 16.67% | |||
| EBITDA | 28.53% | 25.56% | |||
| EPS Basic | 15.79% | 17.39% | |||
| Normalized Basic EPS | 16.67% | 17.24% | |||
| EPS Diluted | 15.79% | 17.39% | |||
| Normalized Diluted EPS | 16.67% | 17.24% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||